PMID: 6109379Dec 18, 1980Paper

Treatment of dyskinesias with tiapride (author's transl)

La semaine des hôpitaux : organe fondé par l'Association d'enseignement médical des hôpitaux de Paris
R Kocher, V Hobi

Abstract

Tiapride was administered to ten patients with late dyskinesias following either prolonged treatment with neuroleptics (nine cases) or Huntington's chorea (one case). The dosage used was 300 mg daily for four weeks, followed by 300 to 600 mg daily during the next four weeks (the basic neuroleptic treatment was continued without modifying the dosage). An objective study on the severity of the dyskinesia demonstrated a significant improvement during the first four weeks, maintained over the following four weeks. Increasing dosage to 900 mg did not modify the results.

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

La semaine des hôpitaux : organe fondé par l'Association d'enseignement médical des hôpitaux de Paris
H Ollat
Journal of Neurology, Neurosurgery, and Psychiatry
P A PriceC D Marsden
La semaine des hôpitaux : organe fondé par l'Association d'enseignement médical des hôpitaux de Paris
F Laspalles, A Soultanian
La semaine des hôpitaux : organe fondé par l'Association d'enseignement médical des hôpitaux de Paris
E Csanda, F Fornadi
© 2021 Meta ULC. All rights reserved